EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Net Equity Issued and Repurchased (2011 - 2026)

EyePoint (EYPT) posted Net Equity Issued and Repurchased of $166.8 million for Q4 2025, up 2317.2% sequentially from $6.9 million in Q3 2025, and up 10.08% YoY from $151.5 million in Q4 2024.

Analysis

EyePoint (EYPT) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

EyePoint has reported Net Equity Issued and Repurchased for 13 years, with the latest figure at $166.8 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased rose 10.08% year-over-year to $166.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $337.4 million (down 14.3% YoY) and the FY2025 annual result came in at $173.4 million, up 6.2% from the prior year.
  • Net Equity Issued and Repurchased grew to $166.8 million in Q4 2025 per EYPT's latest filing, from $6.9 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $230.0 million in Q4 2023 and troughed at -$7.3 million in Q3 2021.
  • A 4-year average of $84.5 million and a median of $63.9 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • The widest YoY moves for Net Equity Issued and Repurchased: up 470.21% in 2021, down 252.06% in 2021.
  • Over 4 years, Net Equity Issued and Repurchased stood at -$7.3 million in 2021, then jumped by 3243.36% to $230.0 million in 2023, then sank by 34.12% to $151.5 million in 2024, then climbed by 10.08% to $166.8 million in 2025.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $166.8 million, $6.9 million, and $151.5 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 20.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.20 Mn
Dec 31, 2025 166.79 Mn
Sep 30, 2025 6.90 Mn
Dec 31, 2024 151.52 Mn
Sep 30, 2024 12.20 Mn
Dec 31, 2023 230.00 Mn
Sep 30, 2021 -7.32 Mn
Jun 30, 2021 -1,000.00
Mar 31, 2021 115.67 Mn
Dec 31, 2020 25.12 Mn
Sep 30, 2020 4.81 Mn
Jun 30, 2020 -295,000.00
Mar 31, 2020 20.29 Mn
Dec 31, 2019 1.87 Mn
Sep 30, 2019 2.41 Mn
Jun 30, 2019 43,000.00
Sep 30, 2018 34.47 Mn
Jun 30, 2018 34.47 Mn
Mar 31, 2018 9.27 Mn
Dec 31, 2017 -27.43 Mn